
MRNA vs VIVS
$MRNA vs $VIVS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MRNA vs VIVS: the quick read
- ·MRNA is the larger company by market cap ($89.83B vs $3M).
- ·MRNA has been more active on our scanner (241 vs 18 alerts in 30 days).
- ·VIVS has the smaller float (14.8M vs 354.9M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: VIVS is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·MRNA draws far more of our scanner's attention, 241 unusual-volume alerts in 30 days against 18, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: MRNA is more than 33586x the market cap of VIVS, so the same dollar of news moves VIVS far harder.
- ·They have diverged badly over the year: MRNA is near the top of its 52-week range while VIVS is near the bottom of its own.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MRNA and VIVS on TheDesperateTrader.
- Is MRNA or VIVS the better stock?
- "Better" depends on your goal, and these two are not alike. MRNA is the larger company by market cap ($89.83B vs $3M). MRNA has been more active on our scanner (241 vs 18 alerts in 30 days). VIVS has the smaller float (14.8M vs 354.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MRNA and VIVS?
- The differences that matter: MRNA is roughly 33586x the size of the other by market cap ($89.83B vs $3M); they trade at very different share prices ($224.50 vs $0.17); MRNA sits at 100% of its 52-week range against 0% for VIVS; our scanner flagged MRNA 241 times in the last 30 days against 18 for VIVS. Everything above is measured from the latest completed session and SEC filings.
- Which of MRNA and VIVS is more active right now?
- Right now MRNA is at about 1.6x its normal volume and VIVS is at about 0.4x, so MRNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MRNA or VIVS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MRNA and VIVS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.